These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37890484)

  • 1. Businesses marketing purported stem cell treatments and exosome therapies for COVID-19: An analysis of direct-to-consumer online advertising claims.
    Turner L; Martinez JR; Najjar S; Rajapaksha Arachchilage T; Wang JC
    Stem Cell Reports; 2023 Nov; 18(11):2010-2015. PubMed ID: 37890484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy claims made by US businesses marketing purported stem cell treatments and exosome therapies.
    Turner L; Martinez JR; Najjar S; Arachchilage TR; Sahrai V; Wang JC
    Regen Med; 2023 Oct; 18(10):781-793. PubMed ID: 37795701
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulatory claims made by US businesses engaged in direct-to-consumer marketing of purported stem cell treatments and exosome therapies.
    Turner L; Martinez JR; Najjar S; Arachchilage TR; Sahrai V; Wang JC
    Regen Med; 2023 Nov; 18(11):857-868. PubMed ID: 37867326
    [No Abstract]   [Full Text] [Related]  

  • 4. US businesses engaged in direct-to-consumer marketing of perinatal stem cell interventions following the Food and Drug Administration's enforcement discretion era.
    Turner L; Wang JC; Martinez JR; Najjar S; Rajapaksha Arachchilage T; Sahrai V
    Cytotherapy; 2024 Apr; 26(4):393-403. PubMed ID: 38340106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing "Cell Therapy" Clinics Offering Treatments of Ocular Conditions using Direct-to-Consumer Marketing Websites in the United States.
    Nirwan RS; Albini TA; Sridhar J; Flynn HW; Kuriyan AE
    Ophthalmology; 2019 Oct; 126(10):1350-1355. PubMed ID: 30904542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The US Direct-to-Consumer Marketplace for Autologous Stem Cell Interventions.
    Turner L
    Perspect Biol Med; 2018; 61(1):7-24. PubMed ID: 29805145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct-to-consumer marketing of stem cell interventions by Canadian businesses.
    Turner L
    Regen Med; 2018 Sep; 13(6):643-658. PubMed ID: 30255734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncovering the gray zone: mapping the global landscape of direct-to-consumer businesses offering interventions based on secretomes, extracellular vesicles, and exosomes.
    Asadpour A; Yahaya BH; Bicknell K; Cottrell GS; Widera D
    Stem Cell Res Ther; 2023 May; 14(1):111. PubMed ID: 37138298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study Shows Businesses Selling Unapproved Stem Cell Treatments Have Turned to Long COVID.
    Eastman Q
    JAMA; 2023 Dec; 330(24):2326-2327. PubMed ID: 38019493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Online marketing practices of regenerative medicine clinics in US-Mexico border region: a web surveillance study.
    Chavez J; Shah NA; Ruoss S; Cuomo RE; Ward SR; Mackey TK
    Stem Cell Res Ther; 2021 Mar; 12(1):189. PubMed ID: 33736697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Online seminars as an information source for direct-to-consumer stem cell therapy.
    Hassoun M; Golub S; Greenfield S; Grill JD; Cummings BJ
    Regen Med; 2022 Feb; 17(2):81-90. PubMed ID: 34949108
    [No Abstract]   [Full Text] [Related]  

  • 12. The FDA and the US direct-to-consumer marketplace for stem cell interventions: a temporal analysis.
    Knoepfler PS; Turner LG
    Regen Med; 2018 Jan; 13(1):19-27. PubMed ID: 29327974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical Marketing in the United States, 1997-2016.
    Schwartz LM; Woloshin S
    JAMA; 2019 Jan; 321(1):80-96. PubMed ID: 30620375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on "Cell Therapy" Clinics Offering Treatments of Ocular Conditions Using Direct-To-Consumer Marketing Websites in the U.S.
    Kalavar M; Lovett EA; Nicholas MP; Ross-Hirsch A; Nirwan RS; Sridhar J; Patel S; Flynn HW; Albini TA; Kuriyan AE
    Am J Ophthalmol; 2024 Nov; 267():135-141. PubMed ID: 38880376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Treatments Sold Online Without Prescription Requirements in the United States: Cross-sectional Study Evaluating Availability, Safety and Marketing of Medications.
    Ozawa S; Billings J; Sun Y; Yu S; Penley B
    J Med Internet Res; 2022 Feb; 24(2):e27704. PubMed ID: 34662286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites' marketing of stem cell therapies.
    Murdoch B; Zarzeczny A; Caulfield T
    BMJ Open; 2018 Feb; 8(2):e019414. PubMed ID: 29490963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Claims About Cannabidiol Products: A Retrospective Analysis of U.S. Food and Drug Administration Warning Letters from 2015 to 2019.
    Wagoner KG; Lazard AJ; Romero-Sandoval EA; Reboussin BA
    Cannabis Cannabinoid Res; 2021 Dec; 6(6):559-563. PubMed ID: 34142863
    [No Abstract]   [Full Text] [Related]  

  • 18. Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19.
    Turner L
    Cell Stem Cell; 2020 Jun; 26(6):806-810. PubMed ID: 32464095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond "medical tourism": Canadian companies marketing medical travel.
    Turner L
    Global Health; 2012 Jun; 8():16. PubMed ID: 22703873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weighing up the evidence used by direct-to-consumer stem cell businesses.
    Cook M; Richey A; Brafman DA; Frow EK
    Stem Cell Reports; 2021 Dec; 16(12):2852-2860. PubMed ID: 34767748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.